疫苗研发与免疫规划的规划与优先事项设定
本文回顾了美国一系列战略规划工作,均涉及对新疫苗候选株进行优先排序的过程。美国国家科学院、工程院和医学院的医学研究所参与了三个优先事项设定过程,分别使用婴儿死亡当量(1985-1986)、成本效果(2000)以及基于更广泛多标准系统方法的软件系统实施(2015)。系统方法使用户能够灵活选择、组合、排序、加权和评估代表其视角、假设和特定需求的不同属性,并克服了以往单一指标排序方法的局限。
要点
- 医学研究所参与了三个疫苗优先设定过程:婴儿死亡当量、成本效果和多标准系统方法。
- 多标准系统方法允许用户灵活选择、组合、排序、加权和评估不同属性。
- 系统方法克服了单一指标排序产生的静态列表无法适应新信息的局限。
核心结论
- 多标准决策支持方法可灵活整合不同属性,更好地支持疫苗政策制定。
研究设计与样本
- 本文为综述,回顾了美国三个疫苗优先设定过程:婴儿死亡当量(1985-1986)、成本效果(2000)和基于多标准系统方法的软件系统(2015)。
主要发现
- 婴儿死亡当量方法在1985-1986年使用,成本效果方法在2000年使用,2015年实施了基于更广泛多标准系统方法的软件系统。
- 系统方法可包含前述任一指标及其他多种考虑因素。
- 系统方法使用户能选择、组合、排序、加权和评估代表其视角、假设和特定需求的不同属性。
- 系统方法克服了以往单一指标排序方法产生的列表静态、无法容纳新发病原体信息、科学进展或干预成本与性能变化等局限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We review a sequence of strategic planning efforts over time in the United States, all involving processes to prioritize new vaccine candidates. The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine has been involved in three priority setting processes, each using different metrics and methodologies: infant mortality equivalents (1985-1986), cost-effectiveness (2000), and more recently, the implementation of a software system based on a broader multi-criteria systems approach that can include either of the earlier metrics among other various considerations (2015). The systems approach offers users the flexibility to select, combine, rank, weigh and evaluate different attributes representing their perspectives, assumptions, and particular needs. This approach also overcomes concerns relating to the previous single-metric ranking approaches that yielded lists that, once published, were static, and could not readily accommodate new information about emerging pathogens, new scientific advances, or changes in the costs and performance features of interventions. We discuss the rationale and reasoning behind the design of this multi-criteria decision support approach, stakeholder feedback about the tool, and highlight the potential advantages from using this expanded approach to better inform and support vaccine policies.
引用
- Phelps CE, Madhavan G, Gellin B, et al. Planning and priority setting for vaccine development and immunization. Vaccine. 2016. PMID: 28017444. doi:10.1016/j.vaccine.2016.09.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。